• Executive interview - Race Oncology

    857 views 2 years ago
    Race Oncology is developing bisantrene, which had been the subject of over 40 clinical trials in the 1980s and 1990s as part of Lederle’s search for a safer anthracycline chemotherapy. Despite positive responses in a variety of cancers, especially AML (it was even approved for the treatment of AML in France, but never commercialised), development stopped after Lederle was sold to Wyeth and then Wyeth to Pfizer. Race will be developing bisantrene initially for relapsed/refractory AML and expects to start a pivotal trial for approval in the US around the end of 2018. Show less
    Read more
  • Uploads Play all

    • Edison Think Tank #2 – COVID-19: The race is on - Duration: 50 minutes.

      • 11 hours ago
      What do we know - actually really know - about the pandemic? Is it what it seems on face value? When can we re-open our economies? And when we do, will there be more spending on healthcare?

      In the...
    • Executive Interview - Silence Therapeutics - Duration: 11 minutes, 27 seconds.

      • 17 hours ago
      Silence Therapeutics is developing a new generation of medicines in the increasingly high-profile sector of RNA therapeutics, using the body’s natural mechanism of RNA interference to inhibit the e...
    • Executive interview - IQE - Duration: 5 minutes, 30 seconds.

      • 1 day ago
      In this video, Tim Pullen, IQE's CFO, describes how IQE is responding to the COVID-19 crisis. He discusses how IQE has been affected, explaining that the business has seen little impact on trading ...
    • Executive interview Quixant full - Duration: 8 minutes, 24 seconds.

      • 2 days ago
      Quixant’s CEO, Jon Jayal, runs through the highlights of the group’s FY19 performance and the steps management has taken to return the business to a growth trajectory and improve revenue visibility...
    • Bitesize Briefing: Difficult headlines, discounted markets - Duration: 9 minutes, 28 seconds.

      • 3 days ago
      In this briefing Nicky Stewart and Edison’s chief strategist, Alastair George, discuss his view on markets. These are difficult times for communities as the COVID-19 pandemic passes through the glo...
    • Executive interview – Laboratorios Farmacéuticos ROVI - Duration: 10 minutes, 19 seconds.

      • 3 days ago
      ROVI is a profitable speciality healthcare company that markets ~40 proprietary and in-licensed products across nine core franchises, mainly in its domestic Spanish market. Since obtaining market a...
    • Executive interview – BluGlass - Duration: 4 minutes, 1 second.

      • 3 days ago
      BluGlass’s CEO, Giles Bourne, introduces the company’s proprietary remote plasma chemical vapour deposition (RPCVD) technology. He explains why RPCVD’s ability to produce material at a lower temper...
    • Executive Interview – Premier Miton Investors - Duration: 29 minutes.

      • 6 days ago
      Gervais Williams, head of equities at Premier Miton Investors, gives his thoughts on the COVID-19 pandemic and current market downturn. He discusses the impact the pandemic is having on various com...
    • Executive interview - Expert System - Duration: 8 minutes, 40 seconds.

      • 6 days ago
      Walt Mayo, Expert System’s Group CEO, introduces himself and explains what attracted him to the opportunity at the company. Walt joined the business from Endeavor, a scale-up venture capital firm, ...
    • Edison Think Tank #1 – COVID 19 Learning from Asia’s response - Duration: 44 minutes.

      • 1 week ago
      Edison Think Tanks look behind the lockdowns and experience the detail of how Asia is controlling coronavirus, discover how the world is permanently changing and find out what this means for societ...
    • Executive interview - The MISSION Group - Duration: 12 minutes, 52 seconds.

      • 1 week ago
      James Clifton, CEO of The MISSION Group, discusses how the group is differentiated from other marketing services and agency groups. He then summarises the financial results for 2019, which showed g...
    • Executive interview – Applied Graphene Materials - Duration: 12 minutes, 27 seconds.

      • 1 week ago
      Adrian Potts, the CEO of Applied Graphene Materials (AGM), discusses the company’s commercial progress over the course of the past 12 months, which saw the launch of a number of coatings products b...
    This item has been hidden
  • This item has been hidden
to add this to Watch Later

Add to

Loading playlists...